T + A方案改善免疫微环境,实现晚期HCC优质生存Bevacizumab plus AtezolizumabImprove the Immune Microenvironment and Achieve High Quality Survival of Advanced in HCC
阿力亚·买买提吐尔逊, 张 韬 下载量: 281 浏览量: 359
临床医学进展 Vol.13 No.3, March 30 2023, PDF, HTML, XML DOI:10.12677/ACM.2023.133695 被引量